首页> 外文期刊>The American surgeon. >Evaluation of the Safety and Efficacy of Percutaneous Transhepatic Gallbladder Drainage Combined with Laparoscopic Cholecystectomy for Treating Acute Complicated Cholecystitis
【24h】

Evaluation of the Safety and Efficacy of Percutaneous Transhepatic Gallbladder Drainage Combined with Laparoscopic Cholecystectomy for Treating Acute Complicated Cholecystitis

机译:腹腔镜胆囊切除术治疗急性复杂性胆囊炎的腹腔镜胆囊切除术治疗急性复杂性胆囊炎的安全性和疗效评价

获取原文
获取原文并翻译 | 示例
           

摘要

The rate of acute cholecystitis in patients with severe underlying diseases is currently increasing. Several studies have reported percutaneous transhepatic gallbladder drainage (PTGBD) combined with laparoscopic cholecystectomy (LC) as a safe and reliable therapeutic option in such patients. This study aimed to elucidate the optimal time interval between PTGBD and LC. In total, 65 patients with acute complicated cholecystitis from our hospital were divided into two groups, short-term LC (sLC) and postponed LC (pLC) group according to whether the procedure was performed within 5 days of gallbladder drainage or after 5 days, respectively. The complications after PTGBD, rate of conversion to open surgery, and complications and mortality after LC were compared between the groups. The sLC group showed significantly lesser operating time, blood loss, postoperative peritoneal drainage time, postoperative oral intake time, and complications compared to the pLC group (P 0.05). Other factors such as the length of hospital stay (LOS), conversion to open cholecystectomy, and mortality were not statistically significant between the groups. Combined treatment with PTGBC and sLC showed superior outcomes compared to PTGBC and pLC for acute cholecystitis in severely ill patients, thus constituting a feasible and secure treatment option in specialized centers.
机译:目前正在增加严重疾病患者急性胆囊炎的速率。几项研究报告了经皮呼吸胸腺细胞引流(PTGBD)与腹腔镜胆囊切除术(LC)联合在此类患者中是一种安全且可靠的治疗选择。本研究旨在阐明PTGBD和LC之间的最佳时间间隔。总共65名患有来自我们医院的急性复杂胆囊炎患者分为两组,短期LC(SLC)和推迟的LC(PLC)组,根据程序是否在胆囊引流的5天内或5天后进行,分别。 PTGBD后的并发症,转化率以开放手术,并在群体之间比较LC后的并发症和死亡率。与PLC组相比,SLC组的操作时间显着较低,失血,术后腹膜引流时间,术后口服摄入时间和并发症(P <0.05)。其他因素如住院住院长度(LOS),转化为开放胆囊切除术以及死亡率之间的统计学意义。与PTGBC和SLC的组合治疗与PTGBC和PLC在严重生病的患者中的PTGBC和PLC与PTGBC和PLC相比表现出优异的结果,从而在专业中心构成了可行和安全的治疗选择。

著录项

  • 来源
    《The American surgeon.》 |2018年第1期|共4页
  • 作者单位

    Jilin Univ Hosp 1 Dept Hepatobiliary &

    Pancreat Surg 71 Xinmin St Changchun 130021 Jilin;

    Jilin Univ Hosp 1 Dept Hepatobiliary &

    Pancreat Surg 71 Xinmin St Changchun 130021 Jilin;

    Jilin Univ Hosp 1 Dept Hepatobiliary &

    Pancreat Surg 71 Xinmin St Changchun 130021 Jilin;

    Jilin Univ Hosp 1 Dept Hepatobiliary &

    Pancreat Surg 71 Xinmin St Changchun 130021 Jilin;

    Jilin Univ Hosp 1 Dept Hepatobiliary &

    Pancreat Surg 71 Xinmin St Changchun 130021 Jilin;

    Jilin Univ Hosp 1 Dept Hepatobiliary &

    Pancreat Surg 71 Xinmin St Changchun 130021 Jilin;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 外科学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号